Announcement: Miromatrix at Cell & Gene Therapy Investor Day

Miromatrix is pleased to announce that it will presenting at the annual Cell & Gene Therapy Investor Day hosted by The Alliance for Regenerative Medicine (ARM) on April 17, 2018 in New York City.  This gathering will provide institutional, strategic and venture investors a chance to learn more about Miromatrix and  our vision to eliminate the transplant waiting list.